IGF-1 LR3

weak data

Also seen as: Long R3 Insulin-Like Growth Factor, long R3 IGF-1, Long R3 IGF-1

The Dose Guy’s verdict

Aug 28, 2026
4 sources

IGF-1 LR3 has a clear mechanism and real community mileage, but zero human data and the one animal growth study came back null. You are injecting a potent, long-acting growth factor with real hypoglycemia risk and no feedback loop to rein it in. For experienced users who have already run the gentler options and understand what a growth factor without a leash means, it is a real tool. If you have not run ipamorelin and CJC-1295 yet, start there.

Would I take it?Caution, a growth signal you can't take back.

What it is

IGF-1 is the molecule HGH works through. Your liver makes it when growth hormone arrives, and it is the actual signal that drives tissue growth, protein synthesis, and nutrient partitioning. IGF-1 LR3 is a synthetic analog engineered to resist binding proteins, the chaperones that normally mop up free IGF-1 and keep it in check. The result: a form that stays unbound and active far longer than the native molecule, hitting harder per microgram and carrying a different risk profile.

Running it directly skips the pituitary, skips the liver, skips every feedback loop that keeps natural GH pulses self-limiting. The secretagogue path is the opposite: compounds like ipamorelin and CJC-1295 ask your body to release more of its own GH, which then makes IGF-1 in a regulated way. IGF-1 LR3 is the end product injected from outside, and your body has no good way to dial it back.

What the research shows

No human trials. Zero. Everything below is animal or in-vitro work. Read it as “interesting,” not “evidence it works in you.”

No human trial exists. Everything below is animal and cell work.

One week of IGF-1 LR3 infusion in fetal sheep increased heart, adrenal, and spleen weights versus saline, each at P below 0.05. It grows organs.Am J Physiol 2021 · fetal sheep · n=16

In growth-restricted fetal sheep, one week of IGF-1 LR3 did not improve fetal growth compared with vehicle. The growth signal hit organs but not the whole animal.Am J Physiol 2025 · growth-restricted fetal sheep · n=14

One week of infusion lowered plasma insulin (P=0.0135) and glucose (P=0.0012) versus vehicle, and impaired glucose-stimulated insulin secretion both in vivo (P=0.0453) and in isolated islets (P=0.0447).Am J Physiol 2021 · fetal sheep

Seven months of intranasal IGF-1 LR3 remodeled amyloid plaques but did not improve cognition in a mouse Alzheimer’s model. Mechanism without functional rescue.J Alzheimers Dis 2025 · 5XFAD mice

No human trial, no human PK study, no human safety data. The PubMed corpus is entirely preclinical.as of Aug 2026

Realistic protocols

People run IGF-1 LR3 for localized muscle growth, pinning it sub-q or intramuscularly into lagging body parts, typically bilaterally for symmetry. The logic is site enhancement, a community practice rather than a measured effect: the idea is that IGF-1 LR3 at the muscle means local satellite-cell activation, and people report visible fullness in the targeted area within a couple of weeks.

Dose low and cycle short. The extended activity that makes it potent is the same property that makes it hard to control, and hypoglycemia is real. Keep fast carbs on hand for every injection, eat around your doses, and never run it fasted. Most people hold at 20 to 50 mcg per day split across injection sites and cycle for four to six weeks before taking at least an equal stretch off. Longer runs push diminishing returns and accumulating risk for a compound with no human safety curve to guide you.

Start20 mcg/daySplit bilaterally into target muscles, sub-q or IM. Keep carbs nearby.

Working range20-50 mcg/dayStay here. More does not improve the result and hypo risk climbs.

Cycle length4-6 weeksOff for at least equal time. No human data says how long is safe.

TimingPost-trainingPin after the session, with a meal. Never fasted.

Side effects

The risk here is the mechanism, not the side-effect list:

monitorHypoglycemia. IGF-1 LR3 lowers blood glucose directly. Dizziness, shaking, sweating, confusion. Eat around every dose and keep sugar within reach.

commonWater retention, pumps, and joint tightness, the standard signs that growth signaling is up.

anecdotalGut distension with prolonged or high-dose use, reported in forums. The same growth signal that fills a bicep does not skip organs.

unknownA potent, unregulated growth factor with zero human safety data. Growth signals do not discriminate between the tissue you want bigger and the tissue you do not. Cycle short, dose low, and respect the absence.